CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 13, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, announced today that its President and Chief Executive Officer, John Maraganore, Ph.D., has been appointed to the Board of Directors of the Biotechnology Industry Organization (BIO). Dr. Maraganore is one of seven new Board members who will each serve three-year terms. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the U.S. and 31 other nations. The mission of BIO is to be the champion of biotechnology and the advocate for its member organizations.
